SCENESSE (afamelanotide) — Topline data
Dec 2026
Top line results from the CUV105 study are due in December 2026.Source filing
CUVL biotech catalysts & pipeline
CLINUVEL PHARMACEUTICALS LTD · Data as of 2026-10-25
catalyst calendar
/
catalyst calendar
CLINUVEL PHARMACEUTICALS LTD · Data as of 2026-10-25
Dec 2026
Top line results from the CUV105 study are due in December 2026.Source filing